STD diagnostics market seen reaching $17.52 billion by 2030

The Business Research Company projects the global STD diagnostics market will grow from $10.77 billion in 2025 to $17.52 billion by 2030, driven by rising STI cases, rapid testing demand and broader use of molecular diagnostics. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - The STD diagnostics market is expanding as sexually transmitted infection rates rise and more testing moves into rapid, home-based and molecular formats. - The market forecast signals growing demand for tools that can support earlier diagnosis, treatment and public health surveillance. - More accessible testing can also reduce barriers tied to privacy, stigma and clinic availability.

What happened: - The Business Research Company released its "STD Diagnostics Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035" on Aug. 27, 2026. - The report projects the global STD diagnostics market will rise from $10.77 billion in 2025 to $11.91 billion in 2026. - The market is forecast to reach $17.52 billion by 2030. - The report pegs the market's 2025-2026 CAGR at 10.6% and its 2026-2030 CAGR at 10.1%.

The details: - STD diagnostics are methods used to detect infections transmitted through sexual contact. - The report ties recent growth to rising STI prevalence, better diagnostic laboratory infrastructure, expanded public health screening, greater sexual health awareness and wider use of advanced nucleic acid testing. - Future growth is expected to come from stronger demand for rapid diagnostics, more home-testing kits, wider use of molecular diagnostics, larger public health surveillance spending and more confidential testing services. - Key trends in the forecast period include rapid and point-of-care STD tests, automated laboratory systems, at-home testing options and earlier, more precise disease detection. - The report says North America held the largest global market share in 2025. - The Asia-Pacific region is expected to grow fastest during the forecast period. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report says its 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The press release includes links to download a free sample of the report and view the full report.

Between the lines: - Rising congenital syphilis cases in the U.S. illustrate the public health pressure behind continued investment in STD testing. - The CDC reported in September 2025 that congenital syphilis cases rose for a 12th straight year, with nearly 4,000 cases in 2024. - The forecast reflects a broader shift toward testing that is faster, more accessible and easier to use outside traditional labs.

What's next: - The market's next phase of growth will likely hinge on adoption of rapid, molecular and at-home tests. - Public health agencies and providers are expected to keep expanding screening and surveillance efforts as infection rates stay elevated. - The strongest regional growth opportunity appears to be in Asia-Pacific, where healthcare investment and diagnostic capacity are rising.

The bottom line: - STD diagnostics is moving from a specialized testing segment toward a larger, more accessible screening market, with demand supported by infection trends and new testing formats.